Document is current

Article History

Accepted: 4 June 2025

First Online: 30 July 2025

Einhaltung ethischer Richtlinien

:

: G. von Amsberg: 1. Anstellungsverhältnis oder Führungsposition: nein; 2. Beratungs- bzw. Gutachtertätigkeit; Advisory Boards: Roche, BMS, Astellas, Sanofi, Janssen, MSD, Merck, Pfizer, Bayer, Amgen, EISAI, Novartis, Lilly, Astra Zeneca, Ipsen; 3. Besitz von Geschäftsanteilen, Aktien oder Fonds: nein, 4. Patent, Urheberrecht, Verkaufslizenz: nein; 5. Honorare/Vorträge/Reisekosten/Kongressunterstützung Roche, BMS, Astellas, Sanofi, Janssen, MSD, Merck, Pfizer, Bayer, Amgen, EISAI, Astra Zeneca, Ipsen; 6. Finanzierung wissenschaftlicher Untersuchungen im Rahmen Industrie-gesponserter Studien (Roche, BMS, MSD, Astra Zeneca, Sanofi, Lilly, EISAI, Amgen, AvenCell, Ipsen). W. Alsdorf: invited speaker Janssen Cilag GmbH. A. Coym: invited speaker Ipsen GmbH. C. Bokemeyer: Consulting fees: AOK Germany (invited speaker), Astra Zeneca (advisory board/invited speaker), Bayer Healthcare (advisory board), BioNTech (advisory board), Lindis Biotech (advisory board), Sanofi Aventis (advisory board/lectures). Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: med update (invited Speaker /organisation for medical education), Merck Serono (advisory board/invited speaker), Roche Pharma (invited speaker). Participation on a Data Safety Monitoring Board or Advisory Board: German Society of Hematology and Oncology (DGHO) (advisory role, Board of DGHO advisors), Hamburg Cancer Society (leadership role), German Cancer Society (DKG) (advisory role, board of directors oncology center certification committee), National Network of German Cancer Centers (CCC)/German Cancer Aid (DKH) (leadership role), Northern German Society of Internal Medicine (NWGIM) (member of board of directors). Other financial or non-financial interests: More than 95 clinical trials, local PI, institutional. No financial interest, our department is involved in several clinical trials sponsored by industry and cooperative groups where we hold participants roles and local PI/PI roles. A. Omlin: Advisory role: (compensated, institutional): Abbvie, Accord, Advanced accelerator applications (AAA), Astra Zeneca, Astellas, Bayer, Janssen, Monrol, Merck, MSD, Myriad, Novartis, Pfizer, Roche (compensated, institutional). Travel support: Astellas, Bayer, Janssen. S. Dyshlovoy gibt an, dass kein Interessenkonflikt besteht.

: Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.